Risk Of Takeda's Actos Found Equal To GSK's Avandia In Comparative Trial
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical's Actos (pioglitazone) diabetes drug was found in a comparative study to cause as many heart problems as GlaxoSmithKline's Avandia (rosiglitazone)